Evidence map›Paper›PMID 24763530›Full record

ArticlePloS one2014

Nrf2 negatively regulates melanogenesis by modulating PI3K/Akt signaling.

Jung-Min Shin, Mi Yoon Kim, Kyung-Cheol Sohn, So-Young Jung, Hae-Eul Lee, Jae Woo Lim, Sooil Kim, Young-Ho Lee, Myung Im, Young-Joon Seo and 4 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 59 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. The Pathogenesis of Oxidative Stress-Induced Chloasma and Its Therapeutic Implications.Clinical, cosmetic and investigational dermatology · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Dimethyl Itaconate Inhibits Melanogenesis in B16F10 Cells.Antioxidants (Basel, Switzerland) · 2023
    Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Connecting Metabolic Rewiring With Phenotype Switching in Melanoma.Frontiers in cell and developmental biology · 2022
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Jung-Min ShinDepartment of Dermatology and Research Institute for Medical Sciences, School of Medicine, Chungnam National University, Daejeon, Korea.
Mi Yoon KimDepartment of Dermatology and Research Institute for Medical Sciences, School of Medicine, Chungnam National University, Daejeon, Korea.
Kyung-Cheol SohnDepartment of Dermatology and Research Institute for Medical Sciences, School of Medicine, Chungnam National University, Daejeon, Korea.
So-Young JungDepartment of Dermatology and Research Institute for Medical Sciences, School of Medicine, Chungnam National University, Daejeon, Korea.
Hae-Eul LeeDepartment of Dermatology and Research Institute for Medical Sciences, School of Medicine, Chungnam National University, Daejeon, Korea.
Jae Woo LimDepartment of Dermatology and Research Institute for Medical Sciences, School of Medicine, Chungnam National University, Daejeon, Korea.
Sooil KimDepartment of Anatomy, School of Medicine, Chungnam National University, Daejeon, Korea.
Young-Ho LeeDepartment of Anatomy, School of Medicine, Chungnam National University, Daejeon, Korea.
Myung ImDepartment of Dermatology and Research Institute for Medical Sciences, School of Medicine, Chungnam National University, Daejeon, Korea.
Young-Joon SeoDepartment of Dermatology and Research Institute for Medical Sciences, School of Medicine, Chungnam National University, Daejeon, Korea.
Chang Deok KimDepartment of Dermatology and Research Institute for Medical Sciences, School of Medicine, Chungnam National University, Daejeon, Korea.
Jeung-Hoon LeeDepartment of Dermatology and Research Institute for Medical Sciences, School of Medicine, Chungnam National University, Daejeon, Korea.
Young LeeDepartment of Dermatology and Research Institute for Medical Sciences, School of Medicine, Chungnam National University, Daejeon, Korea.
Tae-Jin YoonDepartment of Dermatology and Institute of Health Sciences, School of Medicine, Gyeongsang National University, Jinju, Korea.
Chungnam National University · KRGyeongsang National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nrf2 plays a role in protection of cells against oxidative stress and xenobiotic damage by regulating cytoprotective genes. In this study, we investigated the effect of Nrf2 on melanogenesis in normal human melanocytes (NHMCs). When NHMCs were transduced with a recombinant adenovirus expressing Nrf2, melanin synthesis was significantly decreased. Consistent with this result, overexpression of Nrf2 decreased the expression of tyrosinase and tyrosinase-related protein 1. The inhibitory effect of Nrf2 was reversed by overexpression of Keap1, an intracellular regulator of Nrf2. Interestingly, Nrf2 overexpression resulted in marked activation of PI3K/Akt signaling. Conversely, inhibition of PI3K activity by treatment with wortmannin reversed the depigmentary effects of Nrf2. Taken together, these results strongly suggest that Nrf2 negatively regulates melanogenesis by modulating the PI3K/Akt signaling pathway.

Indexed as

AdenoviridaeAndrostadienesCells, CulturedHumansIntracellular Signaling Peptides and ProteinsKelch-Like ECH-Associated Protein 1MelaninsMelanocytesMembrane GlycoproteinsMonophenol MonooxygenaseNF-E2-Related Factor 2Oncogene Protein v-aktOxidoreductasesPhosphatidylinositol 3-KinasesProtein Kinase InhibitorsSignal TransductionAndrostadienesIntracellular Signaling Peptides and ProteinsKEAP1 protein, humanKelch-Like ECH-Associated Protein 1MelaninsMembrane GlycoproteinsMonophenol MonooxygenaseNFE2L2 protein, humanNF-E2-Related Factor 2Oncogene Protein v-aktOxidoreductasesPhosphatidylinositol 3-KinasesProtein Kinase InhibitorsTYRP1 protein, humanWortmannin

Identifiers

PMID24763530
PMCPMC3999113
OpenAlexW2068671512

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.